Novo Nordisk has filed for regulatory approval of the ultra-long-acting insulins Degludec and DegludecPlus in Europe. According to their press release Novo will also be submitting both drugs to the FDA within two weeks. Both drugs will be available with a pen delivery system.
Read More »Diabetes In Control
Special Edition: Early Insulin Initiation
More and more of our patients are developing diabetes, many of them at a much earlier age, so treatment has to be more focused and intense: the sooner this starts the better. This Special Edition brings you the background and basis for starting insulin therapy earlier. Two leading endocrinologists, Dr. …
Read More »Viewpoints on Early Insulin Initiation
Diabetes In Control staff contacted several physicians all across the US to find out what they had to say about early insulin initiation. What they said may surprise you….
Read More »The Role of Insulin Pens in Addressing Barriers to Insulin Therapy
The advantages of insulin pens may reduce resistance to initiating and adhering to insulin therapy. Many patients resist insulin initiation due to concerns about complexity or a general resistance to injections; many patients’ concerns about insulin initiation may stem from perceptions about the pain and inconvenience of using vials and …
Read More »Editor’s Note: Our One-Year Anniversary
This week marks one year since we started delivering our Diabetes Clinical Mastery Series newsletter, and Steve, Andrew, Heather and I appreciate the great support you have given us. According to your emails, the Homerun Slides have provided great materials for your talks, and there have been enough comments about …
Read More »Managing Clinical Problems in Diabetes, Case Study #23: Type 1 and Pre-Teens
Edited by Trisha Dunning AM, RN, MEd, PhD, CDE, FRCNA and Glenn Ward MBBS, BSc, DPhil (Oxon), FRACP, FRCPath Jade, an 11-year-old girl, was admitted via the emergency department with hyperglycemia, ketonuria and a weight loss of 6 kg over the past 4 weeks. The only history of diabetes in …
Read More »Pathophysiology in the Treatment of Type 2 Diabetes: Newer Agents, Part 5 of 5
This week we conclude our five-part series of Homerun Slides on Pathophysiology in the Treatment of Type 2 Diabetes: New Agents. This week’s slides include coverage of Liraglutide and Pramlintide….
Read More »Letter from the Editor #592
This week we bring you more on the EASD and there is an exceptional amount of new information on GLP-1s: I don’t mean just another analog but multiple ways that GLP-1 can be increased in the body, and new ideas on the benefits. According to this week’s Item #2, EASD: …
Read More »Carbohydrate Cheat Sheet
Carbohydrate Cheat Sheet The carb count for the top 50 foods we eat: a simple one page pdf form that your patients can keep with them. Just follow this link to download the Carbohydrate Cheat Sheet.
Read More »Bite Counter = A Pedometer for Your Mouth
Bite Counter = A Pedometer for Your Mouth Count bites by tracking your wrist movement. Researchers have developed a way to fight obesity by helping people answer one fundamental question: how many bites of food are you eating? The Bite Counter, a wristwatch-shaped device being marketed to weight-loss clinics and fitness …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.